Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > MD Providers > Endocrinologists

Dr. Sherita Hill Golden, MD

(Sherita Hill Golden, MD)

(No ratings)

Specializes in: Endocrinology Diabetes & Metabolism

1800 Orleans Street
Baltimore, MD 21287

(410) 955-5000

Dr. Sherita Hill Golden, MD is an endocrinologist in Baltimore, MD specializing in endocrinology diabetes & metabolism. Dr. Sherita Hill Golden, MD is affiliated with The Johns Hopkins Hospital.

Office Locations

1800 Orleans Street
Baltimore, MD 21287

open_in_new

4940 Eastern Avenue
Baltimore, MD 21224

open_in_new

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

The top procedures that Dr. Sherita Hill Golden, MD treated as an endocrinologist in Baltimore, MD during 2012 were lab tests, preventive care and diabetes management.

Volume of procedures performed by Dr. Sherita Hill Golden, MD for Medicare patients.

diabetes management	27
doctor visit	62
lab tests	27
preventive care	27

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. Sherita Hill Golden, MD treated as an endocrinologist in Baltimore, MD during 2013 were hospital care, inpatient care, lab tests and preventive care.

Volume of procedures performed by Dr. Sherita Hill Golden, MD for Medicare patients.

diabetes management	23
doctor visit	76
hospital care	30
inpatient care	30
lab tests	23
preventive care	23

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Sherita Hill Golden, MD.

**Gender**
Male	55
Female	44

**Ethnicity**
Non-Hispanic White	52
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	48
From 75 to 84	0
85 and over	0
Less than 65	27

Conditions of Medicare patients treated by Dr. Sherita Hill Golden, MD in 2013

Hypertension	75
High Cholesterol	74
Stroke	11
Ischemic Heart Disease	51
Depression	28
Chronic Kidney Disease	51
Asthma	12
Osteoperosis	0
Atrial Fibrilation	14
Heart Failure	24
Chronic Obstructive Pulmonary Disease	0
Diabetes	75
Dementia	11
Cancer	11

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

The top procedures that Dr. Sherita Hill Golden, MD treated as an endocrinologist in Baltimore, MD during 2014 were lab tests, preventive care, diabetes management and hospital care.

Volume of procedures performed by Dr. Sherita Hill Golden, MD for Medicare patients.

diabetes management	24
doctor visit	75
hospital care	18
inpatient care	18
lab tests	24
preventive care	24

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Sherita Hill Golden, MD.

**Gender**
Male	43
Female	48

**Ethnicity**
Non-Hispanic White	43
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	51
From 75 to 84	0
85 and over	0
Less than 65	20

Conditions of Medicare patients treated by Dr. Sherita Hill Golden, MD in 2014

Hypertension	75
High Cholesterol	65
Stroke	12
Ischemic Heart Disease	43
Depression	25
Chronic Kidney Disease	44
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	18
Chronic Obstructive Pulmonary Disease	0
Diabetes	75
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

The top procedures that Dr. Sherita Hill Golden, MD treated as an endocrinologist in Baltimore, MD during 2015 were hospital care and inpatient care.

Volume of procedures performed by Dr. Sherita Hill Golden, MD for Medicare patients.

doctor visit	21
hospital care	18
inpatient care	18

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Sherita Hill Golden, MD.

**Gender**
Male	42
Female	48

**Ethnicity**
Non-Hispanic White	0
Black	42
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	44
From 75 to 84	0
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Sherita Hill Golden, MD in 2015

Hypertension	75
High Cholesterol	67
Stroke	0
Ischemic Heart Disease	49
Depression	0
Chronic Kidney Disease	56
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	75
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

Volume of procedures performed by Dr. Sherita Hill Golden, MD for Medicare patients.

doctor visit	36

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Sherita Hill Golden, MD.

**Gender**
Male	12
Female	18

**Ethnicity**
Non-Hispanic White	14
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	17
From 75 to 84	0
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Sherita Hill Golden, MD in 2016

Hypertension	75
High Cholesterol	67
Stroke	0
Ischemic Heart Disease	50
Depression	0
Chronic Kidney Disease	75
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	75
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

Volume of procedures performed by Dr. Sherita Hill Golden, MD for Medicare patients.

doctor visit	33

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Sherita Hill Golden, MD.

**Gender**
Male	13
Female	12

**Ethnicity**
Non-Hispanic White	12
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	14
From 75 to 84	0
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Sherita Hill Golden, MD in 2017

Hypertension	75
High Cholesterol	75
Stroke	0
Ischemic Heart Disease	52
Depression	0
Chronic Kidney Disease	75
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	75
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

Volume of procedures performed by Dr. Sherita Hill Golden, MD for Medicare patients.

doctor visit	15

Conditions of Medicare patients treated by Dr. Sherita Hill Golden, MD in 2018

Hypertension	75
High Cholesterol	75
Stroke	0
Ischemic Heart Disease	0
Depression	0
Chronic Kidney Disease	0
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	75
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

Volume of procedures performed by Dr. Sherita Hill Golden, MD for Medicare patients.

doctor visit	13

Conditions of Medicare patients treated by Dr. Sherita Hill Golden, MD in 2019

Hypertension	75
High Cholesterol	75
Stroke	0
Ischemic Heart Disease	0
Depression	0
Chronic Kidney Disease	0
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	75
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2019

Volume of procedures performed by Dr. Sherita Hill Golden, MD for Medicare patients.

The highest averages for the top procedures that Dr. Sherita Hill Golden, MD treated as an endocrinologist in Baltimore, MD were lab tests, preventive care, diabetes management and hospital care.

diabetes management	24
doctor visit	41
hospital care	22
inpatient care	22
lab tests	24
preventive care	24

Average Medicare Patient Data From 2012 - 2019

Information about Medicare patients treated by Dr. Sherita Hill Golden, MD.

**Gender**
Male	20
Female	21

**Ethnicity**
Black / African American	5
Asian / Pacific Islander	0
Non-Hispanic White	15
Native American / Alaskan Native	0
Hispanic	0
Other	0

**Age**
75 to 84	0
85 and over	0
Less than 65	5
65 to 74	21

Average of Total of Conditions of Medicare patients treated by Dr. Sherita Hill Golden, MD From 2012 - 2019

The highest averages of the most common conditions of Medicare patients that Dr. Sherita Hill Golden, MD treated were diabetes, hypertension, high cholesterol and chronic kidney disease.

Hypertension	65
High Cholesterol	62
Stroke	2
Ischemic Heart Disease	30
Depression	6
Chronic Kidney Disease	37
Asthma	1
Osteoporosis	0
Heart Failure	5
Chronic Obstructive Pulmonary Disease	0
Diabetes	65
Atrial Fibrillation	1
Dementia	1
Cancer	1

Education & Training

She has a state license in Maryland.

Licensed In: Maryland

Ratings & Reviews

Dr. Sherita Hill Golden, MD does not have any reviews yet, be the first to leave a review of Dr. Sherita Hill Golden, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Sherita Hill Golden, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Abbott Laboratories	$17,271 FREESTYLE LIBRE 3 $16,309	Freestyle Libre 2 $962
Genentech, Inc.	$3,128 $3,128
Novo Nordisk Inc	$2,790 $2,790
Allergan, Inc.	$2,500 OZURDEX $2,500
Medtronic, Inc.	$1,440 $1,440
Other	$93 Da Vinci Surgical System $71	LANTUS $22

**Types of Payments**
Consulting Fee	$21,868
Travel and Lodging	$2,493
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$1,440
Food and Beverage	$1,421

Biography

Dr. Sherita Hill Golden is the Hugh P. McCormick Family Professor of Endocrinology and Metabolism. She holds joint appointments in the Welch Center for Prevention, Epidemiology, and Clinical Research, in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, and in the Armstrong Institute for Patient Safety and Quality. An internationally recognized physician-scientist and member of the National Academy of Medicine, the Association of American Physicians, and the American Society of Clinical Investigation, Dr. Golden’s epidemiological research interests focus on two areas: (1) endogenous sex hormones as risk factors for CVD, type 2 diabetes, and insulin resistance in post-menopausal women and (2) mental health complications of diabetes and the biological, hormonal, and behavioral factors that might explain these associations. Her health services research focuses on understanding and eliminating diabetes health disparities and implementing and evaluating systems interventions to improve patient safety and quality of care in hospitalized patients with diabetes. She serves as the Principal Investigator of the Johns Hopkins site of the Diabetes Prevention Program Outcome Study.She is the author of more than 275 articles focused on diabetes, endocrinology, and health disparities. In order to more directly address the root causes of health inequities identified through her research, Dr. Golden has used her executive leadership roles to develop systems, community, and policy interventions. As inaugural Executive Vice-Chair of the Department of Medicine at Johns Hopkins School of Medicine (2015-2019), she launched a department-wide civic engagement initiative, resulting in programs that addressed community-related concerns and enhanced employee engagement following Baltimore’s civil unrest surrounding the 2015 death of Freddie Gray. During her tenure as Vice President and Chief Diversity Officer for Johns Hopkins Medicine (2019-2024), she oversaw diversity, inclusion, and health equity strategy and operations for the School of Medicine and Johns Hopkins Health System. This included staff training for accurate collection of self-identified patient demographic data; system-wide policies prohibiting patient discrimination and discriminatory aggression toward employees and trainees and allowing the use of chosen names on ID badges; a system-wide in-person and online unconscious bias and anti-oppression education programs; and a system-wide Disability and Accessibility Workgroup. In partnership with JHM Human Resources, she launched the Levi Watkins, Jr. Mentorship Program, which is designed as part of JHM’s talent management strategy focused on identifying and developing high-potential leaders, including those from underrepresented groups. During COVID-19 she facilitated mobile community testing and education for the underserved in Baltimore City and equitable vaccine distribution to non-clinical, minoritized frontline staff across JHM. Dr. Golden is a leader in the national discussion advancing health equity, including supporting Maryland legislators in drafting and testifying in support of state-level health equity policy. In 2017 she was the co-recipient of the Walter Reed Distinguished Achievement Award from the University of Virginia School of Medicine, Medical Alumni Association, and Medical School Foundation, which recognizes professional accomplishment, outstanding innovation, and exemplary leadership in the field of Medicine. In 2018 Dr. Golden was named a winner of the 17th Annual Women Worth Watching Awards from the Profiles in Diversity Journal. She was one of 132 winners from across the globe recognized as an executive leading the way to excellence in the workplace, marketplace, and the world. Dr. Golden is also the recipient of the 2019 University of Virginia Distinguished Alumna Award and in 2020 she was named a Maryland Top 100 Woman. She was named a 2021 Baltimore Sun 25 Woman to Watch and in 2022 was awarded the President’s Award from the University of Maryland Alumni Association